On the 3rd of April Royal DSM has opened a new biotechnology facility at its site in Delft. The state-of-the-art center will accelerate DSM’s biotechnology research and development capabilities for applications in food and nutrition, feed, fuel, pharma and bio-based materials. The completion of this new biotechnology center is part of a €100 million investment program by DSM to scale up R&D in the Netherlands since 2013. The center, which offers the broadest range of biotechnology specializations under one DSM roof, clusters innovation, housing over 400 research and developments experts and builds on a solid history of nearly 150 years of fermentation and biotechnology innovation in Delft.
Feike Sijbesma, CEO/Chairman of the DSM Managing Board, commented; “DSM’s new Biotechnology Center is where our scientists create solutions for societal challenges such as the need to provide all people globally with nutritious food, as well as enabling the transformation from a fossil-based to a bio-renewable-based society.The DSM Biotechnology Center facilitates these needs, in an innovative environment and at an historic location in Delft where we build on nearly 150 years of scientific, academic and commercial activities.”
IFFI congratulates member organization DSM with this achievement and looks forward to visiting this magnet for innovation talent. For more information we refer to the official press release.